MMP Capital, a commercial financing company specializing in equipment financing, leasing and unsecured capital, successfully funded $297 million for customers in 2022, a 45 percent increase year over year compared to 2021.

“MMP Capital is growing organically despite all the headwinds in the macro levels of the economy. We funded nearly $100 million in Q4 of 2022 alone and have set a very strong 2023 forecast for continued growth mainly at the expense of our inferior competitors in the aesthetic medical market,” said John-Paul Smolenski, President and CEO, MMP Capital.

“Despite economist predictions that 2023 will be one of the toughest economic years in contemporary times, we are still running strong, anticipating funding more than $400 million in healthcare finance. 2023 also marks our 10th Anniversary. We look forward to celebrating our ongoing record-breaking success with our devoted MMP family of employees, customers, lending partners and key vendor partners.”

In September 2022, MMP Capital announced a strategic partnership with Deutsche Bank for a $75 million secured warehouse line that has allowed the company to become direct lenders and manage loans in house.

“Having our own facility has been a huge contributor to our growth. The more competitive platform, mixed in with MMP Capital’s already sterling reputation for superior service and fast approval, makes it a no-brainer for healthcare companies to work with us. The industry response has been astounding,” said Smolenski. “I like to say success is contagious. MMP is bigger, faster, and able to offer lower rates. Our customers and vendor partners are certainly enjoying our shared success.”